[ Price : $8.95]
The HHS inspector general says KV Pharmaceutical chairman Mark Hermelin is the first drug company executive to be banned from part...[ Price : $8.95]
FDA tells an appeals court that a lower court ruling that failure-to-warn suits against manufacturers of generic Reglan are preemp...[ Price : $8.95]
FDA grants ISTA Pharmaceuticals three years marketing exclusivity under the Hatch-Waxman Act for eye drug Bromday.[ Price : $8.95]
Phase 3 study data involving a Merck investigational drug show promising results for patients in managing their cholesterol levels...[ Price : $8.95]
A New Jersey federal court rules that an Otsuka Pharmaceutical patent covering antipsychotic Abilify (aripiprazole) is valid and e...[ Price : $8.95]
Neuralstem files an IND with FDA to begin two Phase 1 safety trials for NS1-189 for treating major depression.[ Price : $8.95]
FDAs Dallas District Office warns Ascension Orthopedics of reporting and Quality System violations at its manufacturing facility f...[ Price : $8.95]
FDAs Los Angeles District Office warns Nexgen Pharma of CGMP and other violations at two drug manufacturing facilities.